Associations of deoxyfructosazine and an alpha glucosidase inhibiting antidiabetic agent have a synergistic activity in the treatment of type 2 diabetes

An association of deoxyfructosazine (2-((1R,2S,3R)(1,2,3,4-tetrahydroxybutyl)-5-(2'S,3'R)(2',3',4'-trihydr oxybutyl pyrazine)) (I) and an alpha -glucosidase-inhibiting antidiabetic agent (II). Independent claims are included for pharmaceutical compositions containing these a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	EVERS MICHEL
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An association of deoxyfructosazine (2-((1R,2S,3R)(1,2,3,4-tetrahydroxybutyl)-5-(2'S,3'R)(2',3',4'-trihydr oxybutyl pyrazine)) (I) and an alpha -glucosidase-inhibiting antidiabetic agent (II). Independent claims are included for pharmaceutical compositions containing these associations, and their use in the prevention and/or treatment of type 2 diabetes and its complications. La présente invention concerne l'association de déoxyfructosazine et d'un antidiabétique inhibiteur d'alpha-glucosidase, les compositions pharmaceutiques contenant cette association et leur utilisation dans la prévention et/ ou le traitement du diabète de type 2 et ses complications.